Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ron Sabo
Observed names:
R SABO,
R Sabo,
R. Sabo,
RON SABO
Institution:
Novartis (United States)
Observed institutions:
Robert Wood Johnson University Hospital,
Novartis (United States),
Rutgers Cancer Institute,
Columbia University
OpenAlex ID:
A5113522101
A Dose-Ranging Study of Pegylated Interferon Alfa-2b and Ribavirin in Chronic Hepatitis C
2000
·
Paul Glue
, Regine Rouzier-Panis
, et al.
·
Hepatology
·
245
PDF
Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers*
1997
·
Richard D. Huhn
, Elaine Radwanski
, et al.
·
Clinical Pharmacology & Therapeutics
·
130
The Absolute Oral Bioavailability and??Population-Based Pharmacokinetic Modelling of a Novel Dipeptidylpeptidase-IV Inhibitor, Vildagliptin, in Healthy Volunteers
2007
·
Yan-Ling He
, Brian M Sadler
, et al.
·
Clinical Pharmacokinetics
·
74
The effect of age, gender, and body mass index on the pharmacokinetics and pharmacodynamics of vildagliptin in healthy volunteers
2007
·
Yan‐Ling He
, Ron Sabo
, et al.
·
British Journal of Clinical Pharmacology
·
64
PDF
The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin
2007
·
Y.-L. He
, R. Sabo
, et al.
·
European Journal of Clinical Pharmacology
·
63
Dose Proportionality and the Effect of Food on Vildagliptin, a Novel Dipeptidyl Peptidase IV Inhibitor, in Healthy Volunteers
2007
·
Gangadhar Sunkara
, Ron Sabo
, et al.
·
The Journal of Clinical Pharmacology
·
47
Vildagliptin, a Novel Dipeptidyl Peptidase IV Inhibitor, Has No Pharmacokinetic Interactions With the Antihypertensive Agents Amlodipine, Valsartan, and Ramipril in Healthy Subjects
2007
·
Yan‐Ling He
, Monica Ligueros‐Saylan
, et al.
·
The Journal of Clinical Pharmacology
·
42
Evaluation of Pharmacokinetic Interactions Between Vildagliptin and Digoxin in Healthy Volunteers
2007
·
Yan‐Ling He
, Ron Sabo
, et al.
·
The Journal of Clinical Pharmacology
·
40
Effect of the novel oral dipeptidyl peptidase IV inhibitor vildagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects
2007
·
Yan-Ling He
, Ron Sabo
, et al.
·
Current Medical Research and Opinion
·
38
Pharmacokinetics of Roxithromycin (RU 965)
1988
·
Howard B. Lassman
, Surendra K. Puri
, et al.
·
The Journal of Clinical Pharmacology
·
38
Study of the pharmacokinetic interaction of vildagliptin and metformin in patients with type 2 diabetes
2009
·
Yan-Ling He
, Ron Sabo
, et al.
·
Current Medical Research and Opinion
·
36
Effects of single intravenous doses of recombinant human interleukin-10 on subsets of circulating leukocytes in humans
1999
·
Richard D. Huhn
, Kenneth Pennline
, et al.
·
Immunopharmacology
·
20
PII-12Absolute bioavailability of vildagliptin in healthy subjects
2006
·
Y HE
, R SABO
, et al.
·
Clinical Pharmacology & Therapeutics
·
13
Activity and Tolerance of a Continuous Subcutaneous Infusion of Interferon-α2b in Patients with Chronic Hepatitis C
1997
·
STEVEN SCHENKER
, DAVID CUTLER
, et al.
·
Journal of Interferon & Cytokine Research
·
12
PIII-16Lack of pharmacokinetic interaction between Vildagliptin and Metformin in patients with type 2 diabetes
2006
·
Y HE
, R SABO
, et al.
·
Clinical Pharmacology & Therapeutics
·
11
PIII-19The influence of age, gender and BMI on the pharmacokinetics and pharmacodynamics of vildagliptin
2006
·
Y HE
, R SABO
, et al.
·
Clinical Pharmacology & Therapeutics
·
9
A Thorough QT Study on the Effect of Indacaterol on Cardiac Safety in Healthy Subjects.
2009
·
S Khindri
, R Sabo
, et al.
·
5
Pharmacokinetics and Pharmacodynamics of Aliskiren/Hydrochlorothiazide Single‐Pill Combination Tablets and Free Combination of Aliskiren and Hydrochlorothiazide
2011
·
Jing‐He Yan
, Venkateswar Jarugula
, et al.
·
The Journal of Clinical Pharmacology
·
3
Effect of SCH 48461 on oral cholesterol absorption.
1996
·
D. Cutler
, T. Kosoglou
, et al.
·
Clinical Pharmacology & Therapeutics
·
2
Desloratadine suppresses histamine- and allergen-induced cutaneous wheal and flare responses in allergic subjects during 6 months' treatment
2003
·
C. Banfield
, D. Cutler
, et al.
·
Journal of Allergy and Clinical Immunology
·
1
Pharmacodynamic Effects of Interferon ALFA-2b in Healthy Volunteers
1996
·
P. Glue
, D. Cutler
, et al.
·
Clinical Pharmacology & Therapeutics
·
1
Mechanisms by which vildagliptin reduces postprandial glucose excursions in patients with type 2 diabetes
2008
·
J Wörle
, T Lindenberger
, et al.
·
Zeitschrift für Gastroenterologie
Show more works
View as search
Works count:
22
Citation count:
894
H-index:
13
I10-index:
15
Year
Topic
Type
